A detailed history of Centiva Capital, LP transactions in Organon & Co. stock. As of the latest transaction made, Centiva Capital, LP holds 28,372 shares of OGN stock, worth $417,919. This represents 0.01% of its overall portfolio holdings.

Number of Shares
28,372
Holding current value
$417,919
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$18.65 - $23.03 $529,137 - $653,407
28,372 New
28,372 $542,000
Q3 2023

Nov 14, 2023

BUY
$16.59 - $23.77 $526,500 - $754,364
31,736 New
31,736 $550,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.75B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.